Abstract
We have previously found that a cognition enhancer [(+)-5-oxo-D-prolinepiperidinamide monohydrate] (NS-105) reversed the inhibition of cyclic AMP formation induced by the GABA(B) receptor agonist baclofen. The GABA(B) receptor has been implicated in the pathophysiology of depressive illness. The present experiment was designed to evaluate the antidepressant activity of NS-105 in the forced swimming and learned helplessness tests in rats. NS-105 (1-100 mg/kg, p.o.) significantly decreased immobility time in the forced swimming test, an effect similar to that of desipramine. Repeated administration of NS-105 also reversed the failure to escape in the shuttle-box test of rats previously exposed to inescapable footshock. Biochemical data showed that repeated administration of NS-105 increased the number of GABA(B) receptors in rat cerebral cortex without affecting the binding properties of beta-adrenoceptors and 5-HT2 receptors. In contrast to other antidepressants, NS-105 did not inhibit monoamine uptake in vitro, nor did it change monoamine concentrations in brain tissues or extracellular fluids. These findings suggest that NS-105, which lacks an effect on monoaminergic systems, has potent antidepressant activity, which may invol...Continue Reading
References
Feb 1, 1978·Biochemical Pharmacology·J E LeysenP M Laduron
Feb 1, 1978·Biochemical Pharmacology·P M LaduronJ E Leysen
Feb 15, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Aug 1, 1979·European Journal of Pharmacology·R D PorsoltM Jalfre
Apr 21, 1977·Nature·R D PorsoltM Jalfre
May 7, 1976·Analytical Biochemistry·M M Bradford
Nov 5, 1991·European Journal of Pharmacology·V S Murua, V A Molina
Jul 4, 1989·European Journal of Pharmacology·N MotohashiT Kariya
Oct 1, 1987·British Journal of Pharmacology·J A Gray, A R Green
Aug 1, 1986·Journal of Neurochemistry·F OkadaM Ui
Nov 12, 1986·European Journal of Pharmacology·P D Suzdak, G Gianutsos
Aug 1, 1966·Journal of Neurochemistry·J Glowinski, L L Iversen
May 11, 1984·Journal of Chromatography·M Warnhoff
Jan 3, 1980·Nature·N G BoweryM Turnbull
Oct 3, 1980·Science·S J Peroutka, S H Snyder
Jan 1, 1983·British Journal of Pharmacology·N G BoweryA L Hudson
Jan 1, 1983·Annual Review of Neuroscience·A J Friedhoff, J C Miller
Oct 1, 1983·British Journal of Pharmacology·A R GreenV L Nimgaonkar
Jan 1, 1995·Life Sciences·D R GehlertR W Fuller
Oct 1, 1993·British Journal of Pharmacology·G D Pratt, N G Bowery
Jun 1, 1996·Pharmacology & Toxicology·Y ItohK Kimura
Apr 18, 1997·Brain Research·M OkaK Kimura
Citations
Oct 25, 2003·Brain Research·Tetsuji ItohNobuhiro Ibii
Jan 14, 2000·European Journal of Pharmacology·M HirouchiK Kimura
Sep 24, 1999·Pharmacology, Biochemistry, and Behavior·T OgasawaraK Kimura
Sep 23, 2000·Neuroscience Research·M L KramF Petty
Feb 20, 2010·Drugs·Andrei G Malykh, M Reza Sadaie
Feb 4, 2006·Biochemical and Biophysical Research Communications·Michiko OkaTakuya Fujita
Sep 29, 2004·Biochemical Pharmacology·Scott A SandsS J Enna
Sep 15, 2015·Therapeutic Innovation & Regulatory Science·J J ConnollyH Hakonarson